Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Uncovering Cardiovascular Risk in Patients with Target Blood Pressure
Conversations in CV Risk AssessmentUncovering Cardiovascular Risk in Patients with Target Blood Pressure
uACR and eGFR: A Dual-Marker Approach to Cardiovascular Risk Assessment
Conversations in CV Risk AssessmentuACR and eGFR: A Dual-Marker Approach to Cardiovascular Risk Assessment
Rethinking Chronic Kidney Disease: A Key Driver of Cardiovascular Risk
Conversations in CV Risk AssessmentRethinking Chronic Kidney Disease: A Key Driver of Cardiovascular Risk
The Role of Albuminuria in Assessing Cardiovascular Risk
Conversations in CV Risk AssessmentThe Role of Albuminuria in Assessing Cardiovascular Risk
Management of Elevated Albuminuria: Examining Therapeutic Pathways
Conversations in CV Risk AssessmentManagement of Elevated Albuminuria: Examining Therapeutic Pathways
- advertisement
- advertisement
The Immunomodulating Role of B Cells in IgA Nephropathy: Focus On APRIL
Medical Industry FeatureThe Immunomodulating Role of B Cells in IgA Nephropathy: Focus On APRIL
The Pathogenesis of Complement 3 Glomerulopathy (C3G)
Medical Industry FeatureThe Pathogenesis of Complement 3 Glomerulopathy (C3G)
The Endothelin System and IgAN: Emerging Evidence
Medical Industry FeatureThe Endothelin System and IgAN: Emerging Evidence
IgAN Insights: The Impact of Proteinuria
Medical Industry FeatureIgAN Insights: The Impact of Proteinuria
- 12/19/2025
- 12/17/2025
- 12/16/2025
- 12/15/2025
- 12/15/2025
- 12/11/2025